Marcel Schmocker
Director/Board Member presso BioXpress Therapeutics SA
Profilo
Marcel Schmocker is currently a Director at BioXpress Therapeutics SA and IPRIS AG.
He was formerly a Director at Selexis SA. He received his graduate degree from Duke University in 1986 and his undergraduate degree from the University of Bern in 1983.
Posizioni attive di Marcel Schmocker
Società | Posizione | Inizio |
---|---|---|
BioXpress Therapeutics SA
BioXpress Therapeutics SA BiotechnologyHealth Technology BioXpress Therapeutics SA provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity. The company is headquartered in Plan-les-Ouates, Switzerland. | Director/Board Member | - |
IPRIS AG
IPRIS AG Miscellaneous Commercial ServicesCommercial Services IPRIS AG provides intellectual property management solutions. The firm’s offering renewals, European validation, nationalization and renewal portal. The company was founded by Bruno H. Dalle Carbonare and Hugo van Buel in 2004 and is headquartered in Basel, Switzerland. | Director/Board Member | - |
Precedenti posizioni note di Marcel Schmocker
Società | Posizione | Fine |
---|---|---|
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Director/Board Member | - |
Formazione di Marcel Schmocker
Duke University | Graduate Degree |
University of Bern | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Commercial Services |
BioXpress Therapeutics SA
BioXpress Therapeutics SA BiotechnologyHealth Technology BioXpress Therapeutics SA provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity. The company is headquartered in Plan-les-Ouates, Switzerland. | Health Technology |
IPRIS AG
IPRIS AG Miscellaneous Commercial ServicesCommercial Services IPRIS AG provides intellectual property management solutions. The firm’s offering renewals, European validation, nationalization and renewal portal. The company was founded by Bruno H. Dalle Carbonare and Hugo van Buel in 2004 and is headquartered in Basel, Switzerland. | Commercial Services |
- Borsa valori
- Insiders
- Marcel Schmocker